12-Month Stratified Analysis by Calcification Grade From the SUCCESS Study: New Insights Into a Sirolimus-Eluting Balloon in Real-World PAD Patients

Monday, November 3, 2025

10:45am - 10:52am PT

Speaker(s)

Thomas Zeller, MD

Head Physician Department of Angiology
Universitaets-Herzzentrum Freiburg - Bad Krozingen
Bad Krozingen, Germany

Disclosure(s): Acotec, Ablative Solutions, BD Bard Peripheral Vascular, Boston Scientific, Contego Medical, Cook Medical, Cordis, CSI, Gore & Associates, iVascular, MedAlliance, Medtronic, Micro Medical, R3 Vascular, Recor Medical, Reflow Medical, Reva Medical, Sho: Grants/Research Support Recipient
Acotec, BD Bard, Biotronik, Boston Scientific Corp., Cook Medical, Cordis, Medtronic, Veryan: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness)
ANT: Stockholder - Publicly-traded company (excludes mutual/index funds)
Boston Scientific Corp., Gore & Associates, Medtronic, Shockwave, VentureMed, Veryan, Reflow Medical: Consultant

Disclosure(s):

Thomas Zeller, MD: Acotec, Ablative Solutions, BD Bard Peripheral Vascular, Boston Scientific, Contego Medical, Cook Medical, Cordis, CSI, Gore & Associates, iVascular, MedAlliance, Medtronic, Micro Medical, R3 Vascular, Recor Medical, Reflow Medical, Reva Medical, Sho: Grants/Research Support Recipient
Acotec, BD Bard, Biotronik, Boston Scientific Corp., Cook Medical, Cordis, Medtronic, Veryan: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness)
ANT: Stockholder - Publicly-traded company (excludes mutual/index funds)
Boston Scientific Corp., Gore & Associates, Medtronic, Shockwave, VentureMed, Veryan, Reflow Medical: Consultant